Eric A. Scheinbart, MD practices Integrative and Alternative medicine for cancer and chronic diseases. For more than twenty years, with the conviction to improve health, longevity and the quality of life with Naturopathic Immunotherapies of plant based, organic compounded proprietary blend that stimulates the patient’s natural immune system to heal itself. Dr. Scheinbart is a board-certified physician and Mahareshi Ayurvedic trained physician, a board-Certified diplomat of the American Academy of Anti-Aging and a Fellow of the American College of Nutrition. He has successfully improved the health, longevity and quality of life of patients with prostate, breast, ovarian and pancreatic cancers as well as many other cancers, chronic diseases such as diabetes, and neurodegenerative diseases like MS, Parkinson’s disease and dementia and viruses, such as Herpes, EBV and Covid-19. He has been recognized by the NIH/NCI for his work and presented in Bethesda at the NIH. He has spoken at the Cancer Control Society, the A4M and Society of Integrative Oncology in Shanghai, China the World Medical Conference in Dubai, UAE, European Medical Society in Frankfurt, Amsterdam, Paris and London as well as Canada and USA. Most recently as the keynote speaker in Bangkok, Thailand.

I Khallouki Farid, a medicinal chemist and phytochemist with extensive experience in natural product research. After completing my second PhD at the University of Paul verlaine of Metz (France) in Spring 2003, I pursued postdoctoral Researches in Germany (DKFZ, Heidelberg) 2003-2004, in France (INSERM of Toulouse) (December 2006- till September 2009) and at the UAMS, Little rock, Arkansas, USA (September 2009-February 2010) before attending a permanent position as Professor in Morocco at the University of Moulay Ismail, Morocco. With a deep passion for discovering bioactive compounds from natural sources, I have contributed to several research projects and publications in renowned and elegant scientific journals. My Research Interests include modern chromatography and spectroscopy (NMR and High resolution Mass spectrometry) applied to natural anticancer agents.

Mária Sági holds a Ph.D. in psychology from the Eötvös Lóránd University of Budapest and a C.Sc. (a post doctoral degree Candidate of Sciences) from the Hungarian Academy of Sciences. She has developed the New Homeopathy pioneered by Erich Körbler into an encompassing method of Remote Diagnosis and Healing. It permits the healer to assess the effect of information and to correct the malfunctions according to the Chinese meridian system. She is the author of 12 books and about 150 articles and research papers published in Hungarian and translated into English, French, German, Italian and Japanese. The science director of the Club of Budapest, she lives in Budapest, Hungary.

Professor Dr. Mogana Sundari Rajagopal is a registered pharmacist and a recognized expert in the field pharmaceutical sciences focusing on pharmacology and phytochemistry specializing in natural product drug discovery for women’s health (uterine fibroid, cervical cancer, ovarian cancer, primary dysmenorrhea, ovarian cyst) and formulation development of polyherbal and single herb. She graduated from University of Malaya (BPharm Hons., 2000) and University of Nottingham (PhD., 2014). She is currently the Professor and the Dean of the Faculty of Pharmaceutical Sciences and serves as the Head of Pharmacy Services at the organization Hospital. She has published over 70 international peer-reviewed research papers. She has with her with her 2 patents, 2 trademarks and 1 trade secret including 14 international awards and 7 national awards in prestigious international innovation expo. She also received the Most Dynamic Educational Leadership Award in 2024, Women in Education Leader Award at World Education Congress Award 2023, AVRS Achievement Award 2023 and the Outstanding Woman Researcher in Pharmacy, Venus International Woman Award 2021.

Kushagra is a Doctorate from School of Pharmaceutical Sciences at DPSRU, completed his B. Pharm from Guru Gobind Singh Indraprastha University, Delhi in 2014, and M. Pharm in Pharmaceutics from Pt. B.D Sharma Health and Science University, Rohtak Haryana.

I currently hold the position of Assistant Professor in the Department of Pharmaceutical Biology at the Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia. My professional endeavours involve collaborative initiatives with esteemed institutions such as the Tulane University, New Orleans, USA; College of Medicine, King Khalid University in Abha, Saudi Arabia; the University of Charles Darwin in Darwin, Australia; the Department of Biological Sciences; the Central University of Tamil Nadu, India; and the Indian Council of Medical Research (ICMR), India. During my PhD programme, my research contributions focused on molecular cell biology, specifically delving into the expression patterns of leptin (an Ob gene product) and the cytokines tumour necrosis factor-alpha and interleukins 6 and 8 in the reproductive system, with a particular emphasis on polycystic ovarian syndrome within the Indian population. With 18 years of hands-on experience as a molecular biologist, I have honed my expertise in the innovative CRISPR/Cas9 technology for genome editing. Notably, my proficiency extends to designing targeting and validation strategies for creating mutant mice and other organisms. I have successfully executed gene knockouts, introduced stop codons, implemented N-terminus GFP fusions, and incorporated short mutations like SNPs or HA tags. Over the span of 8 years, I have demonstrated my capabilities by producing three modified mice for experiments and validated projects. Beyond genome editing, I possess a comprehensive understanding of next-generation sequencing (NGS), with a particular focus on the IonTorrent sequencing platform. My knowledge encompasses all aspects, from sample quality control and library construction to operating instruments, assessing runs, and interpreting results. Additionally, I am well-versed in Pac Bio and Illumina platforms, offering consultation on experimental design, library preparation, and result interpretation. Proficient in various software tools such as Benchling (for Sanger sequencing analysis, CRISPR targeting designs, PCR, and qPCR primer design), Ion Reporter for Ion Torrent sequencing, Galaxy, R/R Studio, TrinityRNAseq, and Limma for RNAseq analysis, I bring a wealth of technological expertise to the table. My professional track record includes the successful completion of projects like elucidating the mechanisms of immune impairment in chronic Hepatitis C virus infection and studying gut hormones leptin and ghrelin in H. pylori-positive-related gastric cancer. In collaboration with Nobel laureate Prof. Barry Marshall, I facilitated the development of new therapies for immunocompetence.